Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.

ABSTRACT:

Background

In 2016, the World Health Organisation set a goal to eliminate viral hepatitis by 2030. Robust epidemiological information underpins all efforts to achieve elimination and this systematic review provides estimates of HBsAg and anti-HCV prevalence in the European Union/European Economic Area (EU/EEA) among three at-risk populations: people in prison, men who have sex with men (MSM), and people who inject drugs (PWID).

Methods

Estimates of the prevalence among the three risk groups included in our study were derived from multiple sources. A systematic search of literature published during 2005-2015 was conducted without linguistic restrictions to identify studies among people in prison and HIV negative/HIV sero-status unknown MSM. National surveillance focal points

SUBMITTER: Falla AM 

PROVIDER: S-EPMC5809955 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature